Cipralex® for Anxiety Disorders in Adolescents

• Status: Unknown status
• Trial end date: 2012-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective is to examine whether Cipralex® is effective and safe in the treatment of anxiety disorders in youth. The secondary objective is to identify changes in arousal and stress response from pre- to post-treatment with Cipralex® in youth with anxiety disorders.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Ottawa
• Collaborator: H. Lundbeck A/S
• Treatments: Citalopram; Dexetimide

Criteria

Inclusion Criteria:

• Primary diagnosis of (1 or more)

• Social Phobia

• Generalized Anxiety Disorder

• Separation Anxiety Disorder

• Panic Disorder

• Comorbid depression allowed

Exclusion Criteria:

• Unstable medical condition

• Substance use disorder

• Current diagnosis of OCD

• Lifetime diagnosis of developmental delay, pervasive developmental disorder, psychosis